Cargando…
The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats
Following acute myocardial infarction (MI), early and successful reperfusion is the most effective strategy for reducing infarct size and improving the clinical outcome. However, immediate restoration of blood flow to the ischemic zone results in myocardial damage, defined as “reperfusion‐injury”. W...
Autores principales: | Malka, Assaf, Ertracht, Offir, Bachner‐Hinenzon, Noa, Reiter, Irina, Binah, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226283/ https://www.ncbi.nlm.nih.gov/pubmed/28097005 http://dx.doi.org/10.1002/prp2.272 |
Ejemplares similares
-
I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
por: Barac, Yaron D., et al.
Publicado: (2012) -
Correction: I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
por: Barac, Yaron D., et al.
Publicado: (2013) -
Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome
por: Fisch, Sudeshna, et al.
Publicado: (2020) -
Urocortin Role in Ischemia Cardioprotection and the Adverse Cardiac Remodeling
por: Calderón-Sánchez, Eva M., et al.
Publicado: (2021) -
Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury
por: Prag, Hiran A., et al.
Publicado: (2022)